HNSCC, Response prediction, Radiotherapy, ex vivo assay, homologous recombination deficiency (HRD), tumor infiltrating lymphocytes
HNSCC, response prediction, radiotherapy, ex vivo assay, homologous recombination deficiency (HRD), tumor infiltrating lymphocytes